Skip to content

The Clinical and Economic Impacts of e-Heath on Diabetes

The Clinical and Economic Impacts of e-Heath on Diabetes

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01595269
Acronym
eHealthDM
Enrollment
79
Registered
2012-05-10
Start date
2007-04-30
Completion date
2009-12-31
Last updated
2012-05-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus, Type 2

Keywords

Diabetes, eHealth, Type 2 Diabetes, Education, Calgary Health Region

Brief summary

This project addresses the following Null Hypotheses: 1. There will be no difference will be found in the use of the search engine and the information accessed among the three education modes. 2. There will be no difference in education mode's effect on metabolic control, self-care management practices, and medical resource utilization. 3. There will be no difference in the economic impact on the health care system based on differing education modes.

Detailed description

In addition to the face-to-face education process currently used at the CHR, this project will develop two modes of eHealth education. Education mode 1 (control) is comprised of participants educated using CHR's current traditional face-to-face delivery method, with printed materials and written log journals. These participants will be trained to use the University's web portal if they elect to access internet-based diabetes information. This allows for the tracking of the type and amounts of diabetes information accessed by participants. Education mode 2 (static interface) participants will be educated using digitized forms of the traditional materials provided by CHR as well as an electronic log journal (e-journal) where participants will record their diabetes-related outcomes and behavioural information. Education mode 2 will be assessed and approved by CHR. Education mode 3 (dynamic interface) participants will be educated using the digitized traditional materials from education mode 2 as well as an enhanced dynamic e-journal (visualization of blood glucose and alerts). In addition, this mode will provide informative disease-related internet sites and diabetes news and articles vetted by the medical team. Participants and health professionals will then be able to electronically discuss the content and quality of this information (discussion board). New sites and articles will be added on an ongoing basis. Participants will also have access to a chat room that will encourage information sharing with other education mode 3 participants and health professionals at CHR. Education mode 3 will be assessed and approved by CHR.

Interventions

In addition to the face-to-face education process currently used at the CHR, Education mode 1 (control), Education mode 2 (static interface) and Education mode 3 (dynamic interface) will be used.

Sponsors

The Lawson Foundation
CollaboratorOTHER
Dr. Danièle Pacaud
Lead SponsorINDIV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Aged 18 or older * Literate * Not participating in other clinical trials * Diabetes diagnosed within the last three months * Type 2 diabetes * No medical conditions that could compromise metabolic control * No linguistic, cognitive or psychosocial barriers that would hinder study completion * Computer and internet literate * Access to high-speed internet

Exclusion criteria

* Under the age of 18 * Not literate * Participating in other clinical trials * Diabetes diagnosed greater than three months ago * Type 1 diabetes * Gestational diabetes * Additional medical conditions that could compromise metabolic control * Linguistic, cognitive or psychosocial barriers that would hinder study completion * Not computer and internet literate * No access to high-speed internet

Design outcomes

Primary

MeasureTime frameDescription
Changes in A1Cbaseline, 3, 6, 9, 12 monthsA1C is a measure of metabolic control in diabetes. For this study changes in A1C from baseline to 3, 6, 9 and 12 months were measured. All A1C were measured in provincial laboratories using 6.1% as the upper limit of normal for individuals without diabetes.

Secondary

MeasureTime frameDescription
a reduction in the cost of delivering health information and education processesbaseline and 12 monthsSecondary effects could include a change in the cost of delivering health information and education processes. Potential changes to self-care management practices of people with type II diabetes could lead to a reduced utilization of the heath care system resulting in a positive economic impact.
Changes in Diabetes Knowledgebaseline, 3, 6, 9, 12 monthsChanges in diabetes knowledge from baseline to 3, 6, 9, and 12 months will be measured using a 23 item multiple choice questionnaire devolopped by Fitzgerald et al 1998.
Changes in Diabetes self-care activitiesBaseline, 3, 6, 9 and 12 monthsChanges in diabetes self-care activities from base line to 3, 6, 9, and 12 months will be measured the diabetes self-care activities tool evaluated by Toobert at al (2000).

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026